Terapêutica da hepatite crónica não-A, não-B com interferão alfa recombinado e factores que influenciam a resposta ao tratamento.

To assess the efficacy of therapy with alfa Interferon in chronic hepatitis C (NANB), 18 patients were enrolled in an open trial. Eleven were males and 7 females with a mean age of 43 years. Interferon alfa 2b was used in titrated doses for 9 months and the treatment was started with 5 m.U./Ti. Duri...

Full description

Bibliographic Details
Published in:Acta Médica Portuguesa
Main Authors: F Serejo, F Ramalho, R Marinho, M Raimundo, J Velosa, M C de Moura
Format: Article
Language:English
Published: Ordem dos Médicos 1991-12-01
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/3380